Publicaciones en las que colabora con Tobias Engel (13)

2024

  1. Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes

    Purinergic Signalling, Vol. 20, Núm. 3, pp. 303-309

  2. Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice

    Brain, Behavior, and Immunity, Vol. 120, pp. 121-140

2023

  1. CPEB4–CLOCK crosstalk during temporal lobe epilepsy

    Epilepsia, Vol. 64, Núm. 10, pp. 2827-2840

2022

  1. Analyzing the Role of the P2X7 Receptor in Epilepsy

    Methods in Molecular Biology (Humana Press Inc.), pp. 367-387

  2. Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice

    British Journal of Pharmacology, Vol. 179, Núm. 12, pp. 2986-3006

2021

  1. Elevated blood purine levels as a biomarker of seizures and epilepsy

    Epilepsia, Vol. 62, Núm. 3, pp. 817-828

2020

  1. Characterization of the Expression of the ATP-Gated P2X7 Receptor Following Status Epilepticus and during Epilepsy Using a P2X7-EGFP Reporter Mouse

    Neuroscience Bulletin, Vol. 36, Núm. 11, pp. 1242-1258

  2. High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal lobe epilepsy

    Epilepsia, Vol. 61, Núm. 12, pp. 2795-2810

  3. P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice

    Frontiers in Molecular Neuroscience, Vol. 13

  4. Polyadenylation of mRNA as a novel regulatory mechanism of gene expression in temporal lobe epilepsy

    Brain : a journal of neurology, Vol. 143, Núm. 7, pp. 2139-2153

2019

  1. Context-specific switch from anti- to pro-epileptogenic function of the P2Y1 receptor in experimental epilepsy

    Journal of Neuroscience, Vol. 39, Núm. 27, pp. 5377-5392

2018

  1. Haploinsufficient TNAP mice display decreased extracellular ATP levels and expression of Pannexin-1 channels

    Frontiers in Pharmacology, Vol. 9, Núm. MAR

2016

  1. Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation

    Human Molecular Genetics, Vol. 25, Núm. 19, pp. 4143-4156